Prime Medicine, Inc. Share Price
NASDAQ: PRME | Small CapPrime Medicine, Inc. Stock Performance
Prime Medicine, Inc. Share Price Today
As of 31 October 2026, Prime Medicine, Inc.'s share price is $4.71. The stock opened at $5.03, compared to its previous close of $5.24. During today's trading session, Prime Medicine, Inc.'s share price traded between $4.67 and $5.20, with an average price of $4.94. Over the past 52 weeks, the stock has recorded a high of $5.91 and a low of $2.67. In terms of performance, Prime Medicine, Inc.'s share price has risen by 33.19% over the last six months and is down 4.55% on a year-on-year basis.
Prime Medicine, Inc. Share Price Chart
Prime Medicine, Inc. Quarterly Profit & Loss
All figures in USD
Prime Medicine, Inc. Annual Profit & Loss
All figures in USD
About Prime Medicine, Inc.
Prime Medicine Inc is a biotechnology company focused on developing a new class of genetic medicines designed to provide durable, and potentially curative, treatment options for patients with diseases driven by defined genetic alterations, acquired cellular dysfunction, or dysregulated gene expression. Its program, PM577 for Wilson Disease, is designed to initially correct the H1069Q mutation in the ATP7B gene and is supported by preclinical data showing targeted correction and restoration of copper homeostasis in animal models. In addition, PM647 is being developed for alpha-1 antitrypsin deficiency, or AATD, another liver targeted disease with substantial unmet need.
Prime Medicine, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $3.04 | $4.72 | +54.16% |
Sep 2026 | $3.55 | $3.06 | -16.03% |
Aug 2026 | $2.89 | $3.65 | +25.21% |
Jul 2026 | $3.70 | $2.92 | -20.79% |
Jun 2026 | $3.52 | $3.68 | +3.37% |
May 2026 | $3.46 | $3.56 | +0.56% |
Apr 2026 | $3.56 | $3.54 | +1.72% |
Mar 2026 | $4.48 | $3.48 | -24.84% |
Feb 2026 | $3.76 | $4.63 | +21.20% |
Jan 2026 | $3.50 | $3.82 | +10.72% |
Dec 2025 | $3.73 | $3.45 | -9.69% |
Nov 2025 | $4.92 | $3.82 | -22.67% |